WEBVTT

1
00:00:02.480 --> 00:00:05.360
<v Speaker 1>Welcome to today's show. I'm Kate Woda, director of the

2
00:00:05.400 --> 00:00:09.320
<v Speaker 1>Immunooncology three sixty Summit, or most commonly known as IO

3
00:00:09.320 --> 00:00:12.759
<v Speaker 1>three sixty. The IO three sixty Summit will take place

4
00:00:12.759 --> 00:00:16.920
<v Speaker 1>February tenth through twelfth in Boston, Massachusetts, and I'm excited

5
00:00:16.960 --> 00:00:19.519
<v Speaker 1>to give you a sneak peek into what's ahead and

6
00:00:19.559 --> 00:00:22.039
<v Speaker 1>what we'll be diving into this year and why this

7
00:00:22.199 --> 00:00:26.679
<v Speaker 1>meeting is so incredibly important in the oncology space. We

8
00:00:26.760 --> 00:00:29.199
<v Speaker 1>have a lot to cover this year. The science is

9
00:00:29.239 --> 00:00:32.719
<v Speaker 1>moving fast, the global landscape is evolving, and a great

10
00:00:32.759 --> 00:00:35.560
<v Speaker 1>deal of innovation is coming out of China right now.

11
00:00:35.759 --> 00:00:39.359
<v Speaker 1>All of this is shaping the direction of amminooncology and

12
00:00:39.640 --> 00:00:42.280
<v Speaker 1>IO three sixty is where we come together to unpack

13
00:00:42.320 --> 00:00:45.399
<v Speaker 1>it all. So what role does IO three sixty play

14
00:00:45.439 --> 00:00:48.920
<v Speaker 1>in bringing the key stakeholders together. IO three sixty was

15
00:00:49.000 --> 00:00:52.240
<v Speaker 1>really designed to be the forum that unites every part

16
00:00:52.280 --> 00:00:57.240
<v Speaker 1>of the cancer immunotherapy ecosystem, from academia and biotech to

17
00:00:57.320 --> 00:01:02.359
<v Speaker 1>pharma investors and regulators, to share insights, address challenges, and

18
00:01:02.479 --> 00:01:07.200
<v Speaker 1>accelerate the next generation of immunooncology treatments. It's about collaboration,

19
00:01:07.640 --> 00:01:10.599
<v Speaker 1>connecting the science with the business to drive meaningful impact

20
00:01:10.840 --> 00:01:13.599
<v Speaker 1>across cancer types and to make the next wave of

21
00:01:13.599 --> 00:01:18.480
<v Speaker 1>immunooncology a reality. The summit spans three days and it's

22
00:01:18.480 --> 00:01:23.040
<v Speaker 1>built on several key pillars pre clinical and discovery, translational,

23
00:01:23.280 --> 00:01:27.680
<v Speaker 1>clinical development, and business aspects. We also dig into the

24
00:01:27.719 --> 00:01:33.359
<v Speaker 1>spaces in between biomarkers, ADCs, imaging, cell therapy, autoimmune disease

25
00:01:33.719 --> 00:01:37.560
<v Speaker 1>combination strategies, and deal making, to name a few. It's

26
00:01:37.560 --> 00:01:40.439
<v Speaker 1>a packed agenda offering a balance look at both the

27
00:01:40.480 --> 00:01:44.319
<v Speaker 1>science and the strategy driving the field forward. This year,

28
00:01:44.400 --> 00:01:49.040
<v Speaker 1>we're especially excited about sessions on novel biologics including cytokines

29
00:01:49.159 --> 00:01:52.799
<v Speaker 1>by specifics and ADCs, as well as in vivo carti

30
00:01:53.079 --> 00:01:57.280
<v Speaker 1>and the growing role of AI in advancing amminotherapy. The

31
00:01:57.400 --> 00:02:00.959
<v Speaker 1>program is intentionally moving beyond PD one I inhibitors and

32
00:02:01.000 --> 00:02:04.280
<v Speaker 1>beyond just T cell focus, because that's what it takes

33
00:02:04.319 --> 00:02:07.079
<v Speaker 1>to move the field forward and improve outcomes for people

34
00:02:07.120 --> 00:02:10.639
<v Speaker 1>living with cancer. And we've built in plenty of flexibility

35
00:02:10.919 --> 00:02:13.719
<v Speaker 1>so attendees can tailor their experience to focus on what

36
00:02:13.840 --> 00:02:18.560
<v Speaker 1>matters most to them. Now, let's talk about our incredible

37
00:02:18.599 --> 00:02:22.000
<v Speaker 1>lineup of keynote speakers. Each of whom is helping define

38
00:02:22.039 --> 00:02:26.360
<v Speaker 1>the next era of immunooncology. We're delighted to have doctor

39
00:02:26.439 --> 00:02:30.479
<v Speaker 1>Jed Wallchok of Wheal Cornell Medicine on Checkpoints and Beyond

40
00:02:30.759 --> 00:02:34.520
<v Speaker 1>the next era of IO. Doctor Miriam Morod of Mount

41
00:02:34.560 --> 00:02:39.159
<v Speaker 1>Sinai School of Medicine on targeting mylloid cells, Doctor Andrea

42
00:02:39.240 --> 00:02:43.639
<v Speaker 1>Cursik of Memorial Sloan Kettering Cancer Center on dostor Lamab's

43
00:02:43.719 --> 00:02:47.759
<v Speaker 1>next chapter, Doctor Ira Mellman of Parker Institute for Cancer

44
00:02:47.840 --> 00:02:54.599
<v Speaker 1>Ammunotherapy on redefining cancer amunotherapy, and doctor Andrew Baum a

45
00:02:54.680 --> 00:02:58.840
<v Speaker 1>Pfizer on strategic innovations and industry trends. All of these

46
00:02:58.879 --> 00:03:02.599
<v Speaker 1>experts share one and thread. They're bringing insights that connect

47
00:03:02.639 --> 00:03:05.840
<v Speaker 1>the science, the business and the future challenges shaping the

48
00:03:05.840 --> 00:03:09.560
<v Speaker 1>growth of IO. And of course we'll once again host

49
00:03:09.560 --> 00:03:12.199
<v Speaker 1>the annual IO three sixty Debate, one of the most

50
00:03:12.240 --> 00:03:16.680
<v Speaker 1>anticipated sessions every year. It's an entertaining and thought provoking

51
00:03:16.719 --> 00:03:21.639
<v Speaker 1>way to explore serious topics in oncology, full of insight, honesty,

52
00:03:22.039 --> 00:03:26.080
<v Speaker 1>and yes, a little humor. It always gets people thinking differently.

53
00:03:27.039 --> 00:03:30.159
<v Speaker 1>Beyond the sessions, IO three sixty is also about connection.

54
00:03:30.639 --> 00:03:34.879
<v Speaker 1>You'll find networking breaks, luncheons, event receptions, and a dedicating

55
00:03:34.879 --> 00:03:38.319
<v Speaker 1>partnering tool that helps facilitate one on one meetings a

56
00:03:38.360 --> 00:03:42.800
<v Speaker 1>great way to discuss collaborations and partnerships. Our exhibit hall

57
00:03:42.879 --> 00:03:47.479
<v Speaker 1>is curated specifically for the immunooncology, cell and gene therapy communities.

58
00:03:47.960 --> 00:03:50.759
<v Speaker 1>It's not overwhelming like a massive trade show. It's the

59
00:03:50.840 --> 00:03:54.879
<v Speaker 1>perfect balance of learning, connection and exploring. And don't miss

60
00:03:54.919 --> 00:03:58.199
<v Speaker 1>the poster sessions, which are always a highlight. They create

61
00:03:58.240 --> 00:04:01.919
<v Speaker 1>another layer of learning and engagement for attendees. For more

62
00:04:01.960 --> 00:04:05.759
<v Speaker 1>information on the program, full agenda, and ways to participate,

63
00:04:06.080 --> 00:04:09.680
<v Speaker 1>visit iothree sixty summit dot com. Once again, the IO

64
00:04:09.800 --> 00:04:14.000
<v Speaker 1>three sixty Summit takes place February ten through twelfth in Boston, Massachusetts.

65
00:04:14.240 --> 00:04:16.720
<v Speaker 1>We hope to see you there. Thanks for tuning in

66
00:04:17.000 --> 00:04:19.240
<v Speaker 1>and stay tuned for more updates as we get closer

67
00:04:19.279 --> 00:04:19.759
<v Speaker 1>to the event.